<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0001566"><a href="http://purl.obolibrary.org/obo/MONDO_0001566">MONDO:0001566</a></h3>
<p><strong>Label:</strong> hypercalcemia (disease)</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018458">MONDO:0018458</a> (familial hypocalciuric hypercalcemia),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_145980">OMIM:145980</a>, <a href="http://purl.obolibrary.org/obo/OMIM_600740">OMIM:600740</a>, <a href="http://www.orpha.net/ORDO/Orphanet_405">Orphanet:405</a>, <a href="http://purl.obolibrary.org/obo/OMIM_145981">OMIM:145981</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0200013">HP:0200013</a> (Neoplasm of fatty tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012031">HP:0012031</a> (Lipomatous tumor) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0009124">HP:0009124</a> (Abnormality of adipose tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004921">HP:0004921</a> (Abnormality of magnesium homeostasis) and <a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003529">HP:0003529</a> (Parathormone-independent increased renal tubular calcium reabsorption) and <a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003127">HP:0003127</a> (Hypocalciuria) and <a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002918">HP:0002918</a> (Hypermagnesemia) and <a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001012">HP:0001012</a> (Multiple lipomas) and <a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0025032">HP:0025032</a> (Abnormality of digestive system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0200013">HP:0200013</a> (Neoplasm of fatty tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012719">HP:0012719</a> (Functional abnormality of the gastrointestinal tract) and <a href="http://purl.obolibrary.org/obo/HP_0200013">HP:0200013</a> (Neoplasm of fatty tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012649">HP:0012649</a> (Increased inflammatory response) and <a href="http://purl.obolibrary.org/obo/HP_0200013">HP:0200013</a> (Neoplasm of fatty tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012647">HP:0012647</a> (Abnormal inflammatory response) and <a href="http://purl.obolibrary.org/obo/HP_0200013">HP:0200013</a> (Neoplasm of fatty tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012091">HP:0012091</a> (Abnormality of pancreas physiology) and <a href="http://purl.obolibrary.org/obo/HP_0200013">HP:0200013</a> (Neoplasm of fatty tissue) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012031">HP:0012031</a> (Lipomatous tumor) and <a href="http://purl.obolibrary.org/obo/HP_0025032">HP:0025032</a> (Abnormality of digestive system physiology) 75.00%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0008200">HP:0008200</a> (Primary hyperparathyroidism) and <a href="http://purl.obolibrary.org/obo/HP_0012031">HP:0012031</a> (Lipomatous tumor) and <a href="http://purl.obolibrary.org/obo/HP_0012719">HP:0012719</a> (Functional abnormality of the gastrointestinal tract) 75.00%</li>
</ul>
</body>
</html>
